B
BSX icon

Bailard’s Boston Scientific BSX Stock Holding History

Bailard’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8M Sell
187,342
-25,855
-12% -$1.4M 0.16% 116
2026
Q1 		$13.4M Buy
213,197
+11,041
+5% +$883K 0.31% 72
2025
Q4 		$19.3M Sell
202,156
-1,291
-0.6% -$127K 0.43% 51
2025
Q3 		$19.9M Sell
203,447
-2,090
-1% -$216K 0.43% 52
2025
Q2 		$22.1M Buy
205,537
+275
+0.1% +$27.8K 0.51% 46
2025
Q1 		$20.7M Buy
205,262
+1,237
+0.6% +$125K 0.53% 44
2024
Q4 		$18.2M Buy
204,025
+270
+0.1% +$23.8K 0.47% 51
2024
Q3 		$17.1M Buy
203,755
+32,637
+19% +$2.57M 0.44% 55
2024
Q2 		$13.2M Buy
171,118
+16,053
+10% +$1.18M 0.36% 60
2024
Q1 		$10.6M Buy
155,065
+31,441
+25% +$2.02M 0.29% 81
2023
Q4 		$7.15M Buy
+123,624
New +$6.6M 0.21% 107

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bailard's BSX Position: Q2 2026 in Review

Bailard reduced its Boston Scientific (BSX) stake by 12% in Q2 2026, selling an estimated $1.4M and leaving 187,342 shares worth $8M. The position accounts for 0.16% of the portfolio, ranked #116.

Bailard first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $22.1M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bailard held 187,342 shares of Boston Scientific worth $8M as of Q2 2026.
  • Bailard sold 25,855 Boston Scientific shares in Q2 2026, an estimated $1.4M.
  • Boston Scientific made up 0.16% of Bailard's portfolio in Q2 2026, its #116 holding.
  • Bailard first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Bailard's Boston Scientific position peaked at $22.1M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.